John Overdeck’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-25,631
Closed -$124K 4186
2019
Q3
$124K Sell
25,631
-18,509
-42% -$97.1K ﹤0.01% 3281
2019
Q2
$255K Sell
44,140
-43,830
-50% -$289K ﹤0.01% 2954
2019
Q1
$618K Buy
87,970
+34,338
+64% +$227K ﹤0.01% 2139
2018
Q4
$346K Sell
53,632
-32,763
-38% -$209K ﹤0.01% 2361
2018
Q3
$604K Buy
+86,395
New +$649K ﹤0.01% 2323
2018
Q1
Sell
-19,554
Closed -$195K 3776
2017
Q4
$195K Sell
19,554
-74,967
-79% -$820K ﹤0.01% 2936
2017
Q3
$1.05M Buy
94,521
+67,221
+246% +$787K ﹤0.01% 1699
2017
Q2
$259K Buy
27,300
+4,386
+19% +$35K ﹤0.01% 2699
2017
Q1
$153K Sell
22,914
-200
-0.9% -$1.19K ﹤0.01% 2758
2016
Q4
$141K Sell
23,114
-3,600
-13% -$17.9K ﹤0.01% 2959
2016
Q3
$137K Sell
26,714
-220
-0.8% -$1.17K ﹤0.01% 3010
2016
Q2
$155K Sell
26,934
-5,669
-17% -$34.5K ﹤0.01% 2781
2016
Q1
$198K Sell
32,603
-42,871
-57% -$256K ﹤0.01% 2596
2015
Q4
$481K Buy
75,474
+6,663
+10% +$42.1K ﹤0.01% 1987
2015
Q3
$414K Buy
+68,811
New +$428K ﹤0.01% 1633

Other funds holding CO

John Overdeck's CO Position: Q4 2019 in Review

John Overdeck sold out of Global Cord Blood Corporation (CO) in Q4 2019, closing a stake of 25,631 shares — an estimated $124K sold.

John Overdeck first reported a position in CO in Q3 2015 and held it in 15 quarters. The position peaked at $1.05M in Q3 2017. 35 funds tracked by Wall St. Rank hold CO as of Q4 2019.

  • John Overdeck reported no remaining Global Cord Blood Corporation position as of Q4 2019 after selling out during the quarter.
  • John Overdeck sold 25,631 Global Cord Blood Corporation shares in Q4 2019, an estimated $124K.
  • John Overdeck first reported a position in Global Cord Blood Corporation in Q3 2015 and held it in 15 quarters.
  • John Overdeck's Global Cord Blood Corporation position peaked at $1.05M in Q3 2017.
  • 35 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2019.

Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.